{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"}],"units":"Participants"}],"description":"Response to TBL12 is defined as SD or better after 2 cycles of TBL12. The evaluation of SD, PR, or CR is based on the report by Blade et al. (1998)","groups":[{"description":"TBL12 is administered orally at a dose of 2 units (of 20 mL each) twice a day, in 4-week cycles, until disease progression or there is sign of disease progression.","id":"OG000","title":"Sea Cucumber Extract (TBL 12)"}],"paramType":"NUMBER","populationDescription":"all patients","reportingStatus":"POSTED","timeFrame":"2 months","title":"Percentage of Patients Who Have Responded to TBL12","type":"SECONDARY","unitOfMeasure":"percentage of participants"}